10/02/2026
Just concluded: NDOVU Cohort Study training for Bomu Hospital clinicians, nurses, adherence counsellors, laboratory technicians and program staff, unveiling a multi-country, multi-site research study.
Bomu hospital facilities are part of the study sites led by the University of Nairobi. The study seeks to investigate the optimal management of failure to Dolutegravir based treatment. Dolutegravir is the current recommended drug for all people living with HIV in the world. This study will generate the evidence to determine the best way forward after Dolutegravir fails to work.
University of Nairobi